Volume 6 Issue 3
May  2015
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2015  >  6(3): 194-196,205
Guo Fang, Zheng Yongjiang. Hyperthyroidism after allogeneic hematopoietic stem cell transplantation: a case report and literature review[J]. ORGAN TRANSPLANTATION, 2015, 6(3): 194-196,205. doi: 10.3969/j.issn.1674-7445.2015.03.013
Citation: Guo Fang, Zheng Yongjiang. Hyperthyroidism after allogeneic hematopoietic stem cell transplantation: a case report and literature review[J]. ORGAN TRANSPLANTATION, 2015, 6(3): 194-196,205. doi: 10.3969/j.issn.1674-7445.2015.03.013
shu

Hyperthyroidism after allogeneic hematopoietic stem cell transplantation: a case report and literature review

doi: 10.3969/j.issn.1674-7445.2015.03.013

  • Guangzhou Women and Children's Medical Center, Guangzhou 510623, China

More Information
  • Corresponding author: Zheng Yongjiang, Email: zhengyongjiang@aliyun.com
  • Received Date: 2015-02-01
    Available Online: 2021-01-19
  • Publish Date: 2015-05-15
    Abstract
  •   Objective  To investigate the characteristics of diagnosis and treatment on hyperthyroidism after allogeneic hematopoietic stem cell transplantation(AHSCT).   Methods  The clinical data of a female patient who suffered from hyperthyroidism after AHSCT at Department of Hematology of the Third Affiliated Hospital, Sun Yat-sen University at December 2008 were analyzed retrospectively. The clinical manifestation, laboratory examination, diagnosis and treatment of the patient were summarized and analyzed, and the relevant literatures were reviewed.   Results  The patient developed the symptoms of hyperthyroidism at 39 months after AHSCT, and had the clinical manifestation and laboratory examination results specific to hyperthyroidism. The patient was diagnosed as diffuse toxic goiter (Graves’ disease) and had good prognosis after drug therapy.   Conclusions  It is rare to develop hyperthyroidism after AHSCT that has specific clinical manifestation and can be confirmed by laboratory examination. Graves' disease has good prognosis with early diagnosis and treatment.

     

    • FullText(HTML)
  • loading
    • References(20)
  • [1]
    Effraimidis G, Wiersinga WM. Mechanisms in endocrinology:autoimmune thyroid disease:old and new players[J]. Eur J Endocrinol,2014,170(6):R241-R252. doi: 10.1530/EJE-14-0047
    [2]
    Au WY, Lie AK, Kung AW, et al. Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation[J]. Bone Marrow Transplant,2005,35(4):383-388. doi: 10.1038/sj.bmt.1704766
    [3]
    Tauchmanovà L, Selleri C, De Rosa G, et al. Endocrine disorders during the first year after autologous stem-cell transplant[J]. Am J Med,2005,118(6):664-670. doi: 10.1016/j.amjmed.2005.02.009
    [4]
    Hou HA, Tang JL, Hsu SC, et al. Acquisition and cure of autoimmune disease following allogeneic hematopoietic stem cell transplantation[J]. J Formos Med Assoc,2007,106(9):779-783. doi: 10.1016/S0929-6646(08)60040-6
    [5]
    Orio F, Muscogiuri G, Palomba S, et al. Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells[J]. Scientific World J, 2014:282147. http://cn.bing.com/academic/profile?id=2083880773&encoded=0&v=paper_preview&mkt=zh-cn
    [6]
    Gunasekaran U, Agarwal N, Jagasia MH, et al. Endocrine complications in long-term survivors after allogeneic stem cell transplant[J]. Semin Hematol,2012,49(1):66-72. doi: 10.1053/j.seminhematol.2011.10.010
    [7]
    Hon C, Yau K, Chan EY, et al. Graves' ophthalmopathy after allogeneic stem cell transplantation[J]. Ann Hematol,2006,85(12):887-888. doi: 10.1007/s00277-006-0183-4
    [8]
    Vardizer Y, Lupetti A, Vandelanotte S, et al. Graves' orbitopathy in a patient with adrenoleukodystrophy after bone marrow transplantation[J]. Eur J Endocrinol,2009,161(2):369-373. doi: 10.1530/EJE-08-0944
    [9]
    Feng YH, Su BA, Lin CY, et al. Hyperthyroidism as a latent complication of autologous hematopoietic stem cell transplantation[J]. Int J Hematol,2008,88(2):237-239. doi: 10.1007/s12185-008-0096-1
    [10]
    Perz JB, Marin D, Szydlo RM, et al. Incidence of hyperthyroidism after unrelated donor allogeneic stem cell transplantation[J]. Leuk Res,2007,31(10):1433-1436. doi: 10.1016/j.leukres.2007.03.004
    [11]
    Jung YJ, Jeon YJ, Cho WK, et al. Risk factors for short term thyroid dysfunction after hematopoietic stem cell transplantation in children[J]. Korean J Pediatr,2013,56(7):298-303. doi: 10.3345/kjp.2013.56.7.298
    [12]
    Tailor IK, Akil M, Rennie I, et al. Reconstitution Graves' disease following autologous haematopoietic stem cell transplantation for severe diffuse systemic sclerosis[J]. QJM,2012,105(4):369-371. doi: 10.1093/qjmed/hcr050
    [13]
    De Waele S, Van den Bruel A, Selleslag D, et al. Acute thyrotoxicosis after SCT[J]. Bone Marrow Transplant,2009,43(8):663-664. doi: 10.1038/bmt.2008.374
    [14]
    Devereaux D, Tewelde SZ. Hyperthyroidism and thyrotoxicosis[J]. Emerg Med Clin North Am,2014,32(2):277-292. doi: 10.1016/j.emc.2013.12.001
    [15]
    Lee HS, Hwang JS. The treatment of Graves' disease in children and adolescents[J]. Ann Pediatr Endocrinol Metab,2014,19(3):122-126. doi: 10.6065/apem.2014.19.3.122
    [16]
    Muldoon BT, Mai VQ, Burch HB. Management of Graves' disease:an overview and comparison of clinical practice guidelines with actual practice trends[J]. Endocrinol Metab Clin North Am,2014,43(2):495-516. doi: 10.1016/j.ecl.2014.02.001
    [17]
    Vaidya B, Pearce SH. Diagnosis and management of thyrotoxicosis[J]. BMJ,2014,349:g5128. doi: 10.1136/bmj.g5128
    [18]
    Berisso GA, van Lint MT, Bacigalupo A, et al. Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease[J]. Bone Marrow Transplant,1999,23(10):1091-1092. doi: 10.1038/sj.bmt.1701760
    [19]
    Ishikawa F, Shigematsu H, Gondo H, et al. Autoreactive antibodies following autologous peripheral blood stem cell transplantation[J]. Bone Marrow Transplant,1998,22(7):729-731. doi: 10.1038/sj.bmt.1701409
    [20]
    Au WY, Lie AK, Kung AW, et al. Thyrotoxic periodic paralysis after allogeneic haematopoietic stem cell transplantation[J]. Br J Haematol,2005,129(1):160-161. doi: 10.1111/bjh.2005.129.issue-1
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (130) PDF downloads(3) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return